Products
16756 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nike Constant Leverage with ISIN code: CH1345999507 | Nike | Constant Leverage | Short | ― | 75.595 | 17.95 | 0.340 | 18.29 | 1 | -0.77 % | -3.91 % | 106.08 % | 18 Apr. 2024 | |
Nokia Constant Leverage with ISIN code: CH1235293177 | Nokia | Constant Leverage | Long | ― | 3.629 | 0.24 | 0.010 | 0.25 | 1 | -4.00 % | 9.09 % | -17.24 % | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 3.629 | 0.84 | 0.010 | 0.85 | 1 | 0.00 % | 7.69 % | -7.69 % | 6 May. 2022 | |
Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 3.629 | 6.48 | 0.030 | 6.51 | 1 | -1.97 % | -9.75 % | -1.37 % | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1345998707 | Nokia | Constant Leverage | Short | ― | 3.629 | 2.8 | 0.020 | 2.82 | 1 | -2.78 % | -15.15 % | -4.76 % | 18 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746238 | Novartis | Constant Leverage | Long | ― | 97.465 | 13.65 | 0.050 | 13.7 | 1 | 0.00 % | 5.41 % | 10.53 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746246 | Novartis | Constant Leverage | Long | ― | 97.465 | 15.55 | 0.100 | 15.65 | 1 | 0.00 % | 7.99 % | 15.61 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 97.465 | 12.49 | 0.050 | 12.54 | 1 | 1.22 % | 5.40 % | 10.83 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 97.465 | 9.72 | 0.100 | 9.82 | 1 | 2.86 % | 13.15 % | 23.98 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1346746253 | Novartis | Constant Leverage | Long | ― | 97.465 | 17.45 | 0.150 | 17.6 | 1 | 0.00 % | 10.09 % | 19.52 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 97.465 | 12.41 | 0.070 | 12.48 | 1 | 1.80 % | 8.10 % | 15.66 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 97.465 | 11.43 | 0.090 | 11.52 | 1 | 2.42 % | 10.76 % | 20.06 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 97.465 | 4.85 | 0.020 | 4.87 | 1 | -0.41 % | -5.09 % | -12.45 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 97.465 | 2.99 | 0.020 | 3.01 | 1 | -0.66 % | -7.72 % | -18.75 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1346746220 | Novartis | Constant Leverage | Short | ― | 97.465 | 6.59 | 0.030 | 6.62 | 1 | -0.75 % | -6.39 % | -13.74 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 97.465 | 1.71 | 0.010 | 1.72 | 1 | 0.00 % | -9.52 % | -24.34 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1346746212 | Novartis | Constant Leverage | Short | ― | 97.465 | 5.21 | 0.030 | 5.24 | 1 | -0.95 % | -9.55 % | -20.46 % | 24 Apr. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 975.313 | 30.08 | 0.120 | 30.2 | 1 | 1.76 % | -11.11 % | 10.39 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587347 | Novo Nordisk | Constant Leverage | Long | ― | 975.313 | 34.34 | 0.200 | 34.54 | 1 | 2.63 % | -17.15 % | 12.41 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 975.313 | 10.45 | 0.300 | 10.75 | 1 | 1.75 % | -37.12 % | 5.24 % | 23 Feb. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.